Donald DeGolyer
Director/Board Member presso EMERGENT BIOSOLUTIONS INC.
Patrimonio netto: 300 235 $ in data 31/03/2024
Profilo
Donald W.
DeGolyer was the founder and had founded Vertice Pharma LLC in 2015, where he held the title of President & Chief Executive Officer.
Currently, he is serving as an Independent Director at Emergent BioSolutions, Inc. since 2023, at Tyme, Inc. since 2018, at Vertice Pharma UK Parent Ltd., at Vertice Pharma UK Holdings Ltd.
as Secretary & Director since 2015, at Vertice Pharma UK Intermediate Ltd.
as Secretary & Director since 2015, and at Xevant, Inc. since 2023.
In his former positions, he served as President & Chief Executive Officer at Sandoz, Inc., Vice Chairman at Association for Accessible Medicines, Independent Director at Tyme Technologies, Inc. from 2018 to 2022, Independent Director at HLS Therapeutics, Inc., Principal at Johnson & Johnson, Vice President-Marketing & Sales at Pfizer Inc., Chief Operating Officer at Endo Pharmaceuticals, Inc. from 2013 to 2015, President-Global Therapeutics at Oxford GlycoSciences Plc, and SVP-Managed Markets & Established Medicines at Novartis Pharmaceuticals Corp.
He also served as Chief Operating Officer & Executive Vice President at ParkStone Medical Info Systems.
Mr. DeGolyer completed his undergraduate degree at Rochester Christian University and holds an MBA from Fairleigh Dickinson University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/10/2023 | 118 670 ( 0.23% ) | 300 235 $ | 31/03/2024 | |
HLS THERAPEUTICS, INC.
-.--% | 18/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Donald DeGolyer
| Società | Posizione | Inizio |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Director/Board Member | 28/09/2023 |
Xevant, Inc.
 Xevant, Inc. Packaged SoftwareTechnology Services Xevant, Inc. is a pharmacy benefits platform that automates and simplifies the process of report building for pbms, tpas, health plans, brokers, and consultants. The company is based in Lehi, UT. The platform infuses real-time automation and alerts throughout the data analysis process, resulting in optimized business processes, reduced operating costs, and improved patient outcomes. Xevant is recognized as one of Modern Healthcare's best places to work and the No. 1 fastest-growing private software company on the 2022 Inc. 5000 list. The company was founded in 2017 by Brandon Newman, who has been the CEO since 2017. | Director/Board Member | 03/07/2023 |
Vertice Pharma UK Holdings Ltd.
 Vertice Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in London, UK and was founded in 2015. | Director/Board Member | 21/10/2015 |
Vertice Pharma UK Intermediate Ltd.
 Vertice Pharma UK Intermediate Ltd. Financial ConglomeratesFinance Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Intermediate Ltd. functions as an investment holding private company. The company is based in London, UK and was founded in 2015. | Director/Board Member | 21/10/2015 |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Director/Board Member | 31/05/2018 |
Vertice Pharma UK Parent Ltd.
 Vertice Pharma UK Parent Ltd. Pharmaceuticals: MajorHealth Technology Vertice Pharma UK Parent Ltd. engages in the activities of a holding company with interest in pharmaceutical industry. The company was founded in 2015 and is headquartered in Berkeley Heights, NJ. | Director/Board Member | - |
Precedenti posizioni note di Donald DeGolyer
| Società | Posizione | Fine |
|---|---|---|
| HLS THERAPEUTICS INC. | Director/Board Member | 16/06/2023 |
| TYME TECHNOLOGIES, INC. | Director/Board Member | 16/09/2022 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Chief Operating Officer | 01/07/2015 |
| ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Donald DeGolyer
| Rochester Christian University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| PFIZER, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Aziende private | 14 |
|---|---|
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
| ParkStone Medical Info Systems | |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Health Technology |
Vertice Pharma LLC
 Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Vertice Pharma LLC operates as a pharmaceuticals company that develops, manufactures, markets, and distributes pharmaceutical products through its operating companies. The company was founded by Donald W. DeGolyer and is headquartered in Berkeley Heights, NJ. | Health Technology |
Vertice Pharma UK Parent Ltd.
Vertice Pharma UK Parent Ltd. Pharmaceuticals: MajorHealth Technology Vertice Pharma UK Parent Ltd. engages in the activities of a holding company with interest in pharmaceutical industry. The company was founded in 2015 and is headquartered in Berkeley Heights, NJ. | Health Technology |
Vertice Pharma UK Holdings Ltd.
Vertice Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in London, UK and was founded in 2015. | Health Technology |
Vertice Pharma UK Intermediate Ltd.
Vertice Pharma UK Intermediate Ltd. Financial ConglomeratesFinance Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Intermediate Ltd. functions as an investment holding private company. The company is based in London, UK and was founded in 2015. | Finance |
Xevant, Inc.
Xevant, Inc. Packaged SoftwareTechnology Services Xevant, Inc. is a pharmacy benefits platform that automates and simplifies the process of report building for pbms, tpas, health plans, brokers, and consultants. The company is based in Lehi, UT. The platform infuses real-time automation and alerts throughout the data analysis process, resulting in optimized business processes, reduced operating costs, and improved patient outcomes. Xevant is recognized as one of Modern Healthcare's best places to work and the No. 1 fastest-growing private software company on the 2022 Inc. 5000 list. The company was founded in 2017 by Brandon Newman, who has been the CEO since 2017. | Technology Services |
- Borsa valori
- Insiders
- Donald DeGolyer
